Surviving in a Post-Advertising World

Schwindt, Oriana
September 2010
Pharmaceutical Representative;Sep2010, Vol. 40 Issue 9, p20
The article focuses on the influence of advertisement (ad) such as online ads on pharmaceutical industries in the U.S. It highlights the initiatives of pharmaceutical companies such as Merck and Co. Inc. to ramp up online ad campaigns though several pharmaceutical companies have been slow to adapt to the shifting marketing landscape. Statements from IMS Consulting principal John Busbice on the shift of pharmaceutical companies to a more centralized management strategy are also presented.


Related Articles

  • prescription drugs. Bittar, Christine // MediaWeek;04/23/2001, Vol. 11 Issue 17, pSR22 

    Deals with the advertising efforts of pharmaceutical companies in the United States for its prescription drugs. Popularity of direct-to-consumer drug advertising and the expectation in its increase for the year 2001; Results of the advertisements released by Merck company for its Vioxx...

  • Head to head struggle. Rosenberg, Janice // Advertising Age;4/3/2000, Vol. 71 Issue 14, pS2 

    Reports on the sales performance of top drugs in the United States in 1999. New and refill prescriptions generated by Searle's arthritis pain reliever Celebrex; Merck & Co.'s release of Vioxx in May 1999; Vioxx and Celebrex's share in the anti-inflammatory drug market; Advertising campaigns for...

  • CRITICAL CONDITION. Thomaselli, Rich // Advertising Age;4/11/2005, Vol. 76 Issue 15, p93 

    Discusses issues on the safety of direct-to-consumer advertised drugs in the U.S. in line with the recall of drug Vioxx from Merck. Criticisms against the Food and Drug Administration regarding the presentation of risk information; Advertising spending of different pharmaceutical companies...

  • Leading Indicators.  // Pharmaceutical Executive;Jun2008, Vol. 29 Issue 6, p14 

    The article highlights various events in the pharmaceutical industry in the U.S. Merck & Co. Inc. has decided to place the kibosh on trial for the MK-0524A to reduce its losses. The city of San Francisco has filed a case against McKesson Corp. for an allegation of drug pricing manipulation. The...

  • FDA May Crack Down on Marketing. N. T. M. // Pharmaceutical Executive;Jun2005, Vol. 25 Issue 6, p26 

    The article reports that the U.S. Food and Drug Administration (FDA) is considering whether it should more aggressively police drug-makers' marketing techniques. The news comes in the wake of the U.S. House Government Reform Committee releasing strategic Merck & Co. Inc. sales materials the day...

  • Merck's ePromotion tops with primary care docs. McGuire, Stephen // Medical Marketing & Media;May2008, Vol. 43 Issue 5, p26 

    The article reports that Merck & Co. Inc. was rated the top ePromotion company in the pharmaceutical industry. It mentions that physicians rated Merck's ePromotion efforts as top in the ePromotion annual survey carried out by Verispan LLC. Out of approximately 1,000 physicians who participated...

  • Merck a leader in video detailing. B. C. // Medical Marketing & Media;Jul2008, Vol. 43 Issue 7, p16 

    The article focuses on the rise in the use of the Internet for advertising in the pharmaceutical industry. Director of client services at Verispan LLC Tara Hann states that Merck & Co. Inc. ranked the highest on the use Internet for promotion and informs that the company held 92% of all video...

  • And the Turkey Goes to…. Sloan, Allan; Jefferson, David J. // Newsweek;11/29/2004, Vol. 144 Issue 22, pE20 

    Presents three corporations or groups of corporations that, according to the author, made poor decisions in 2004. Scrutiny of corporations that began expensing stock options voluntarily; Details of the stock option debate, beginning with the collapse of Enron Corp.; Criticism of Merck, who...

  • Zocor. Thomaselli, Rich // Advertising Age;11/17/2003, Vol. 74 Issue 46, pS-13 

    The article focuses on the application of the advertising tagline "We try harder" on the advertising campaign of Merck & Company's cholesterol-lowering drug Zocor. Perhaps the first pharmaceutical company to incorporate the sports world when it landed Atlanta Falcons coach Dan Reeves several...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics